Alacrita Consulting is a pharma and biotech consulting firm that differentiates itself by offering a team of industry-leading consultants with extensive expertise in developing and commercializing drug products. Founded in 2009, the company prides itself on the first-hand experience of its subject-matter experts, who have dedicated their careers to various aspects of the drug product lifecycle, including discovery, development, manufacturing, and commercialization. The core team at Alacrita is supported by a network of over 250 experts who contribute specialist knowledge when necessary, ensuring that clients receive tailored support for a range of R&D and business issues. The firm stands out by offering speed and flexibility in line with professional life science consulting standards. Alacrita's expertise spans various domains including clinical development, CMC & supply chain, regulatory affairs, and business planning, among others. The company also offers services in asset scouting, due diligence, and pharmaceutical and biotech valuations, showcasing a comprehensive approach to supporting clients in maximizing value at each stage of pharmaceutical product development. With its comprehensive range of services and a team of seasoned experts, Alacrita Consulting stands as an attractive proposition for venture capital investors seeking to tap into the lucrative pharmaceutical and biotech consulting industry. Learn more at www.alacrita.com.
There is no investment information
No recent news or press coverage available for Alacrita Consulting.